Cabinet Approves Thailand’s Advance Market Commitment for COVID-19 Vaccine

The Cabinet, during its meeting on 17 November 2020, approved a project on Thailand’s Advance Market Commitment for the COVID-19 vaccine from AstraZeneca (Thailand) and AstraZeneca (UK).

The project, proposed by the Ministry of Public Health, involves a budget of more than six billion baht. In this project, AstraZeneca will produce 26 million doses of the COVID-19 vaccine for 20 percent of the Thai population, or 13 million people.

The Thai government is aware of the importance of producing and supplying a COVID-19 vaccine of high quality for the people. With the Advance Market Commitment, Thailand is expected to have the vaccine available in the 2021 fiscal year.

The project will reduce the number of COVID-19 patients and the death toll from the disease. This will bring down medical costs resulting from taking care of persons infected with COVID-19 and help in the country’s economic and social rehabilitation.

Deputy Prime Minister and Public Health Minister Anutin Charnvirakul said that if the AstraZeneca trials on the COVID-19 vaccine were successful, Thailand would be among the first countries in the world to have access to the vaccine.

The Advance Market Commitment will also provide Thailand with technology transfer of vaccine production from abroad, so that Thailand will be able to produce its own vaccine in the country.

 

Source: The Government Public Relations Department

Post Author: web Desk